These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 14664659

  • 1. Retrospective drug utilization review: incidence of clinically relevant potential drug-drug interactions in a large ambulatory population.
    Peng CC, Glassman PA, Marks IR, Fowler C, Castiglione B, Good CB.
    J Manag Care Pharm; 2003; 9(6):513-22. PubMed ID: 14664659
    [Abstract] [Full Text] [Related]

  • 2. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM, Mikkola JA, Laine K, Airaksinen M.
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [Abstract] [Full Text] [Related]

  • 3. Effect of nationwide concurrent drug utilization review program on drug-drug interactions and related health outcome.
    Kim DS, Je NK, Park J, Lee S.
    Int J Qual Health Care; 2021 Aug 28; 33(3):. PubMed ID: 34402911
    [Abstract] [Full Text] [Related]

  • 4. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R, Baer R, Aparasu A.
    Res Social Adm Pharm; 2007 Dec 28; 3(4):426-37. PubMed ID: 18082877
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a wireless handheld medication management device in the prevention of drug-drug interactions in a Medicaid population.
    Malone DC, Saverno KR.
    J Manag Care Pharm; 2012 Dec 28; 18(1):33-45. PubMed ID: 22235953
    [Abstract] [Full Text] [Related]

  • 6. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
    Malone DC, Abarca J, Skrepnek GH, Murphy JE, Armstrong EP, Grizzle AJ, Rehfeld RA, Woosley RL.
    Med Care; 2007 May 28; 45(5):456-62. PubMed ID: 17446832
    [Abstract] [Full Text] [Related]

  • 7. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV, Guaraldo L, Japiassú AM, Bozza FA.
    J Clin Pharm Ther; 2015 Feb 28; 40(1):63-7. PubMed ID: 25329640
    [Abstract] [Full Text] [Related]

  • 8. Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
    Somogyi-Végh A, Ludányi Z, Erdős Á, Botz L.
    BMC Pharmacol Toxicol; 2019 May 31; 20(1):36. PubMed ID: 31151485
    [Abstract] [Full Text] [Related]

  • 9. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy.
    Gagne JJ, Maio V, Rabinowitz C.
    J Clin Pharm Ther; 2008 Apr 31; 33(2):141-51. PubMed ID: 18315779
    [Abstract] [Full Text] [Related]

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
    Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557
    [Abstract] [Full Text] [Related]

  • 11. Potential drug-drug interactions within Veterans Affairs medical centers.
    Mahmood M, Malone DC, Skrepnek GH, Abarca J, Armstrong EP, Murphy JE, Grizzle AJ, Ko Y, Woosley RL.
    Am J Health Syst Pharm; 2007 Jul 15; 64(14):1500-5. PubMed ID: 17617500
    [Abstract] [Full Text] [Related]

  • 12. A clinical evaluation of the Janus Web Application, a software screening tool for drug-drug interactions.
    Mannheimer B, Ulfvarson J, Eklöf S, Bergqvist M, von Bahr C.
    Eur J Clin Pharmacol; 2008 Dec 15; 64(12):1209-14. PubMed ID: 18695980
    [Abstract] [Full Text] [Related]

  • 13. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
    Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL, Lipton RB.
    J Am Pharm Assoc (2003); 2004 Dec 15; 44(2):142-51. PubMed ID: 15098848
    [Abstract] [Full Text] [Related]

  • 14. Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data.
    Solberg LI, Hurley JS, Roberts MH, Nelson WW, Frost FJ, Crain AL, Gunter MJ, Young LR.
    Am J Manag Care; 2004 Nov 15; 10(11 Pt 1):753-9. PubMed ID: 15623265
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinically relevant potential drug-drug interactions among outpatients: A nationwide database study.
    Jazbar J, Locatelli I, Horvat N, Kos M.
    Res Social Adm Pharm; 2018 Jun 15; 14(6):572-580. PubMed ID: 28716467
    [Abstract] [Full Text] [Related]

  • 19. Relationship between pharmaceutical services characteristics and exposure rates to drug-drug interactions in Veterans Affairs medical centers.
    Mahmood MH, Armstrong EP, Malone DC, Skrepnek GH.
    Am J Health Syst Pharm; 2008 Sep 15; 65(18):1744-9. PubMed ID: 18769002
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.